EXPRESSION AND DISTRIBUTION OF ATRIAL-NATRIURETIC-PEPTIDE IN HUMAN HYPERTROPHIC VENTRICLE OF HYPERTENSIVE HEARTS AND HEARTS WITH HYPERTROPHIC CARDIOMYOPATHY

被引:67
|
作者
TAKEMURA, G
FUJIWARA, H
MUKOYAMA, M
SAITO, Y
NAKAO, K
KAWAMURA, A
ISHIDA, M
KIDA, M
UEGAITO, T
TANAKA, M
MATSUMORI, A
FUJIWARA, T
IMURA, H
KAWAI, C
机构
[1] KYOTO UNIV, FAC MED,DEPT INTERNAL MED,DIV 3,54 KAWARA CHO, SAKYO KU, KYOTO 606, JAPAN
[2] KYOTO UNIV, FAC MED, DEPT INTERNAL MED, DIV 2, KYOTO 606, JAPAN
[3] KYOTO WOMENS UNIV, KYOTO, JAPAN
关键词
VENTRICLE; HYPERTENSION; ATRIAL NATRIURETIC PEPTIDE; HYPERTROPHIC CARDIOMYOPATHY;
D O I
10.1161/01.CIR.83.1.181
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To investigate the ventricular expression of atrial natriuretic peptide (ANP) in human hypertrophic hearts, we conducted an immunohistochemical study of 130 endomyocardial biopsy specimens obtained from the right side of the ventricular septum (RVB), left ventricular free wall (LVB), or both from a total of 80 patients: 44 patients with hypertrophic cardiomyopathy (HCM), 14 with apical hypertrophic cardiomyopathy (APH), 13 with hypertensive hearts (HHD), and nine without hypertrophy (controls). No patients had apparent congestive hearts (HHD), and nine without hypertrophy (controls). No patients had apparent congestive heart failure. ANP was not seen in ventricular myocytes in controls but was identified in biopsy specimens of hypertrophic hearts, and its distribution was characteristic in each hypertrophic group: 15 RBV (37%) and two LVB (7%) of the HCM group, one RBV (7%) and two LVB (18%) of the APH group, and zero RVB (0%) and five LVB (46%) of the HHD group. Clinical data (including echocardiographic, hemodynamic, and angiographic data) were not directly related to ventricular ANP expression in HCM, APH, or HHD with one exception. In HHD patients, LVB specimens with ANP showed greater ventricular wall thickness than LVB specimens without ANP. According to histological data, however, the ANP-present RVB specimens without ANP. According to histological data, however, the ANP-present RVB specimens of HCM or ANP-present LVB specimens of HHD had greater myocyte size than did the ANP-absent specimens. In addition, in HCM patients, the ANP-present RVB specimens showed more severe fibrosis and myofiber disarray than did the ANP-absent specimens. We conclude that a failing state and hemodynamic overload are not likely to be indispensable for ANP expression in human hypertrophic ventricles and that ventricular ANP expression occurs as a response to disease-specific changes: hemodynamic overload in HHD and histological changes such as myocardial fiber disarray, hypertrophy of myocytes, and fibrosis in HCM, which may reflect the characteristic distribution of intraventricular ANP.
引用
收藏
页码:181 / 190
页数:10
相关论文
共 50 条
  • [21] Plasma atrial natriuretic peptide is elevated in patients with hypertrophic cardiomyopathy
    Fahy, GJ
    McCreery, CJ
    OSullivan, F
    Keenan, AK
    Quigley, PJ
    Maurer, BJ
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 1996, 55 (02) : 149 - 155
  • [22] Atrial natriuretic peptide gene polymorphism is not associated with hypertrophic cardiomyopathy
    Xue Hao
    Wang Hu
    Wang Xiao-jian
    Sun Kai
    Wang Shu-xia
    Song Xiao-dong
    Hui Ru-tai
    [J]. CHINESE MEDICAL JOURNAL, 2010, 123 (02) : 188 - 192
  • [23] ATRIAL-NATRIURETIC-PEPTIDE (ANP) RELEASE IN CALVES WITH ARTIFICIAL HEARTS (AH)
    WESTENFELDER, C
    BARANOWSKI, RL
    KABLITZ, C
    OLSEN, DB
    BURNS, G
    JAHAN, S
    [J]. KIDNEY INTERNATIONAL, 1986, 29 (01) : 389 - 389
  • [24] DECREASED RATES OF RELEASE OF ATRIAL-NATRIURETIC-PEPTIDE FROM ISOLATED HEARTS FROM AGING HYPERTENSIVE RATS
    OPIE, LH
    OWEN, P
    DUTOIT, E
    NORTON, GG
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 1992, 5 (10) : 748 - 753
  • [25] Can serum carnitine levels distinguish hypertrophic cardiomyopathy from hypertensive hearts?
    Nakamura, T
    Sugihara, H
    Kinoshita, N
    Yoneyama, S
    Azuma, A
    Nakagawa, M
    [J]. HYPERTENSION, 2000, 36 (02) : 215 - 219
  • [26] EFFECT OF ENDURANCE TRAINING ON ATRIAL-NATRIURETIC-PEPTIDE GENE-EXPRESSION IN NORMAL AND HYPERTROPHIED HEARTS
    MANTYMAA, P
    AROKOSKI, J
    PORSTI, I
    PERHONEN, M
    ARVOLA, P
    HELMINEN, HJ
    TAKALA, TES
    LEPPALUOTO, J
    RUSKOAHO, H
    [J]. JOURNAL OF APPLIED PHYSIOLOGY, 1994, 76 (03) : 1184 - 1194
  • [27] THE FIBROGENETIC ROLE OF MYOCARDIAL FIBER DISARRAY IN NORMALS, HYPERTENSIVE HEARTS AND HYPERTROPHIC CARDIOMYOPATHY
    TANAKA, M
    ONODERA, T
    WU, DJ
    MATSUDA, M
    TAKEMURA, G
    ISHIDA, M
    KAWAMURA, A
    FUJIWARA, H
    KAWAI, C
    [J]. JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1987, 51 (08): : 971 - 971
  • [28] QUANTITATIVE-ANALYSIS OF MYOCARDIAL FIBROSIS IN NORMAL HEARTS AND HEARTS WITH HYPERTROPHIC CARDIOMYOPATHY
    TANAKA, M
    ONODERA, T
    WU, DJ
    FUJIWARA, H
    KAWAI, C
    [J]. JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1986, 50 (03): : 290 - 290
  • [29] SYNTHESIS AND DISTRIBUTION OF ATRIAL-NATRIURETIC-PEPTIDE (ANP) IN HEARTS FROM NORMAL DOGS AND THOSE WITH CARDIAC ABNORMALITIES
    COLBATZKY, F
    VOLLMAR, A
    MONCH, U
    HERMANNS, W
    [J]. JOURNAL OF COMPARATIVE PATHOLOGY, 1993, 108 (02) : 149 - 163
  • [30] IMMUNOHISTOCHEMICAL STUDY OF HUMAN ATRIAL NATRIURETIC POLYPEPTIDE IN THE HEARTS WITH DILATED CARDIOMYOPATHY AND THE HEARTS WITH VALVULAR DISEASE
    TAKEMURA, G
    FUJIWARA, H
    WU, DJ
    MATSUDA, M
    ISHIDA, M
    KAWAMURA, A
    KIDA, M
    JEGAITO, T
    KAWAI, C
    MUKOYAMA, M
    SAITO, Y
    NAKAO, K
    IMURA, H
    FUJIWARA, T
    [J]. JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1988, 52 (08): : 887 - 887